Clinical Trial Update: F-18 Sodium Fluoride in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating F-18 Sodium Fluoride for imaging in prostate cancer has completed. Results were posted on 2014-12-24.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• F-18 Sodium Fluoride (fluorine-18 sodium fluoride)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2014-12-24